Pharmacoepidemiology

Pharmacoepidemiology may be defined as the study of the utilization and effects of drugs in large numbers of people. To accomplish this study, pharmacoepidemiology borrows from both pharmacology and epidemiology. Thus, pharmacoepidemiology can be called a bridge science spanning both pharmacology and epidemiology. (ISPE Website)

Comparative Effectiveness Research (CER)

The IOM defines CER as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat and monitor a clinical condition, or to improve the delivery of care. The purpose of CER is to assist consumers, clinicians, purchasers, and policy makers to make informed decisions that will improve health care at both the individual and population levels.

Systems Biology and Computational Biology

Understanding the molecular basis of diseases from a network perspective is a research focus of Panayiotis (Takis) Benos, PhD, and Madhavi Ganapathiraju, PhD.

Human Computer Interaction and Evaluation

Friedman's "fundamental theorem" of biomedical informatics states that the combination of human intelligence and information resources is more powerful than human intelligence alone. Realizing the potential benefits of this combination requires careful attention to the design and evaluation of user interfaces that will help users maximize the utility of information resources. Harry Hochheiser, PhD uses techniques of contextual inquiry and prototyping to develop bioinformatics interfaces for the FaceBase project.

PA Biosurveillance

Funding Agency: 
PA Dept of Health
Grant/Contract No.: 
SAP #40000012020
Project Dates: 
01/01/2008 to 06/30/2013

The purpose of the project was to maintain and expand the Commonwealth of Pennsylvania’s public health surveillance system.

The University of Pittsburgh's Comparative Effectiveness Research Scholars Program

Funding Agency: 
Agency for Healthcare Research and Quality
Grant/Contract No.: 
K12 HS019461-01
Project Dates: 
07/01/2010 to 06/30/2013

This intramurally awarded K grant provided me with salary support during my transition to becoming an independently-funded, translational scientist. It supported tuition for training in comparative effectiveness research and pharmacoepidemiology. As part of this grant, I developed my research program in informatics to improve medication safety.

The Quality of Warfarin Use in Veterans Affairs Nursing Homes

Funding Agency: 
VA Center for Medication Safety (VA Pharmacy Benefits Management (PBM) Services)
Grant/Contract No.: 
PBM008
Project Dates: 
07/01/2008 to 09/30/2009

Using a Clinical Event Monitor to Detect Adverse Drug Reactions in Long-Term Care

Funding Agency: 
National Institute of Health, Roadmap/NCRR/University of Pittsburgh Multidisciplinary Clinical Research Career Development Award (Federal)
Grant/Contract No.: 
05KL2RR024154-04
Project Dates: 
07/01/2005 to 06/30/2010
^